Idacorp Market Sentiment

Idacorp Inc

IDANYSE

$140.68

-1.38-0.97%

Últ. Act.: Oct 23, 4:00 PM

Panorámica general Noticias Previsión de beneficios Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Dividendo: La fecha límite del dividendo es dentro de 12 días

Ganancias: Beneficios de Q3 2026 dentro de 5 días de ahora en jue oct 29th, antes de la apertura del mercado

Conferencia telefónica: Conferencia telefónica programada para dentro de 5 días a las 4:30 p. m.

Haz clic para ver el webcast

Idacorp Market Sentiment - Benzinga

Idacorp Market Sentiment

Market sentiment signals for Idacorp (IDA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 13.8% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

9 analysts

Options Flow (P/C)

0.00

More calls — Bullish

1 calls · 0 puts

Avg Consensus PT

$141

-0.0%

Highest Price Target

$155

+10.2%

Wells Fargo

Lowest Price Target

$125

-11.1%

Wells Fargo

Short Interest

13.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	Morgan Stanley	David Arcaro—	+2.4%	$143 → $144	Maintained	Overweight
Oct 9, 2026	Barclays	Michael Lonegan—	+5.9%	$162 → $149	Maintained	Overweight
Sep 18, 2026	Morgan Stanley	David Arcaro—	+1.6%	$151 → $143	Maintained	Overweight
Aug 21, 2026	Morgan Stanley	David Arcaro—	+7.3%	$156 → $151	Maintained	Overweight
Aug 3, 2026	Barclays	Michael Lonegan—	+15.2%	$167 → $162	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Shahriar Pourreza—	+10.2%	$154 → $155	Maintained	Equal-Weight
Jul 22, 2026	Wells Fargo	Shahriar Pourreza—	+9.5%	$121 → $154	Upgrade	Underweight→Equal-Weight
May 5, 2026	Barclays	Michael Lonegan—	+18.7%	$159 → $167	Maintained	Overweight
Apr 21, 2026	Morgan Stanley	David Arcaro—	+12.3%	$160 → $158	Maintained	Overweight
Apr 8, 2026	Barclays	Michael Lonegan—	+13.0%	$149 → $159	Maintained	Overweight
Feb 24, 2026	Barclays	Michael Lonegan—	+5.9%	$144 → $149	Maintained	Overweight
Feb 20, 2026	Mizuho	Anthony Crowdell—	+5.2%	$141 → $148	Maintained	Outperform
Feb 20, 2026	UBS	William Appicelli—	+0.9%	$134 → $142	Maintained	Neutral
Feb 2, 2026	Morgan Stanley	David Arcaro—	+3.1%	$146 → $145	Maintained	Overweight
Jan 28, 2026	Jefferies	Julien Dumoulin-Smith—	+6.6%	$152 → $150	Maintained	Buy
Jan 20, 2026	Wells Fargo	Shahriar Pourreza—	-16.1%	$129 → $118	Downgrade	Equal-Weight→Underweight
Jan 14, 2026	Barclays	Michael Lonegan—	+2.4%	$144	Initiate	Overweight
Dec 17, 2025	UBS	William Appicelli—	-8.3%	$135 → $129	Maintained	Neutral
Dec 16, 2025	Morgan Stanley	David Arcaro—	-1.2%	$137 → $139	Upgrade	Equal-Weight→Overweight
Dec 1, 2025	Jefferies	Julien Dumoulin-Smith—	+8.0%	$155 → $152	Maintained	Buy
Oct 28, 2025	Wells Fargo	Shahriar Pourreza—	-8.3%	$129	Initiate	Equal-Weight
Oct 27, 2025	Mizuho	Anthony Crowdell—	+2.4%	$129 → $144	Maintained	Outperform
Oct 22, 2025	Jefferies	Julien Dumoulin-Smith—	+10.2%	$144 → $155	Maintained	Buy
Sep 26, 2025	Jefferies	Julien Dumoulin-Smith—	+2.4%	$135 → $144	Maintained	Buy
Sep 25, 2025	Morgan Stanley	David Arcaro—	-6.9%	$133 → $131	Maintained	Equal-Weight